Cart
sales@molnova.com
Bevirimat
CAS No. 174022-42-5
Bevirimat( PA-457 | MPC-4326 | YK FH312 )
Catalog No. M20655 CAS No. 174022-42-5
Bevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 119 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 155 | In Stock |
|
| 25MG | 345 | In Stock |
|
| 50MG | 500 | In Stock |
|
| 100MG | 714 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBevirimat
-
NoteResearch use only, not for human use.
-
Brief DescriptionBevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
-
DescriptionBevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
-
In Vitro——
-
In Vivo——
-
SynonymsPA-457 | MPC-4326 | YK FH312
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research AreaInfection
-
IndicationHIV-1 Infection
Chemical Information
-
CAS Number174022-42-5
-
Formula Weight584.83
-
Molecular FormulaC36H56O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (85.49 mM)
-
SMILES[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C
-
Chemical Name(1R3aS5aR5bR7aR9S11aR11bR13aR13bR)-9-((3-carboxy-3-methylbutanoyl)oxy)-5a5b8811a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Smith P F Ogundele A Forrest A et al. Phase I and II Study of the Safety Virologic Effect and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3′3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection[J]. Antimicrobial Agents & Chemotherapy 2007 51(10):3574.
molnova catalog
related products
-
HIV-1 Rev 34-50
HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity. HIV-1 Rev peptide is a one of the cell-penetrating peptides (CPPs) derived from HIV-1 Rev protein residue 34-50. It is a RNA binding peptideand has been used to deliver macromolecules into cells.
-
Zalcitabine
A pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS.
-
Elvitegravir
Elvitegravir (GS-9137, JTK-303) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM in cell-free assays, respectively.
